Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL

Clinical trial NCT05811845 · RECRUITING

Trial details

NCT number: NCT05811845
Sponsor: IRCCS Burlo Garofolo
Status: RECRUITING
Study type: OBSERVATIONAL

Acute Lymphoblastic Leukemia

Start date: 2022-07-30
Primary completion: 2025-07-30
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.